Mirae Asset Global Investments Co., Ltd. Cyma Bay Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $24 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024
BUY
$12.63 - $24.47 $6,630 - $12,846
525 Added 1.09%
48,669 $1.15 Million
Q3 2023

Oct 26, 2023
BUY
$10.86 - $17.62 $1,096 - $1,779
101 Added 0.21%
48,144 $717,000
Q2 2023

Aug 10, 2023
BUY
$7.47 - $10.95 $358,881 - $526,070
48,043 New
48,043 $526,000

Others Institutions Holding CBAY

# of Institutions
6
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email